MIRNA FOR TREATING HEAD AND NECK CANCER

The invention relates to the diagnostic and therapeutic uses of a miRNA-323, miRNA-342, miRNA-326, miRNA-371, miRNA-3157 and/or miRNA-345 molecule, an equivalent or a source thereof in a disease and condition associated with a squamous cell carcinoma such as head and neck cancer or a preneoplastic m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOMMANS, WILLEMIJN MARIA, DE KEMP, SANNE ROSALY, SCHAAPVELD, ROELAND QUIRINUS JOZEF, PREVOST, GREGOIRE PIERRE ANDRE, CERISOLI, FRANCESCO, BRAKENHOFF, RUDOLF HENRIKUS, VAN DER PLAS, MARLON
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the diagnostic and therapeutic uses of a miRNA-323, miRNA-342, miRNA-326, miRNA-371, miRNA-3157 and/or miRNA-345 molecule, an equivalent or a source thereof in a disease and condition associated with a squamous cell carcinoma such as head and neck cancer or a preneoplastic mucosal change. L'invention concerne des utilisations de diagnostic et thérapeutique d'une molécule miARN-323, miARN-342, miARN-326, miARN-371, miARN-3157 et/ou miARN-345, un équivalent ou une source de celles-ci, dans une maladie et un état associés à un carcinome à cellules squameuses, tel que le cancer de la tête et du cou, ou une modification prénéoplasique de muqueuse.